Fig. 3From: The O-glycosylating enzyme GALNT2 acts as an oncogenic driver in non-small cell lung cancerClinical significance of GALNT2 in NSCLC. A Nomogram predicting overall survival probability. B ROC curves. C Detection of GALNT2 expression by RT-qPCR in NSCLC tissues. D Analysis of GALNT2 protein expression in NSCLC tissues by UALCAN. E TCGA pan-cancer analysis of GALNT2. NS, no significance; *P < 0.05; **P < 0.01; ***P < 0.001Back to article page